This document summarizes the hospitalization and death of a 71-year-old female patient who presented with right knee pain and a fractured humerus. During her hospital stay, she developed acute kidney injury, anemia, suspected heart failure, and was found to have a colon mass. Her condition deteriorated and she passed away. The final diagnoses were suspected heart failure, acute kidney injury, anemia, and colon mass. Areas for potential improvement and differential diagnoses are not specified.
A Case presentation of Massive Transfusion in post LSCS PPH patientDrShinyKajal
workup at blood centre
components issued
transfusion summary
criteria for massive transfusion
goal of massive transfusion
Indication protocol for massive transfusion for whole blood, prbc, ffp, cryo, platelets
Targets of resuscitation in massive blood loss
Complications of Massive Transfusion
citrate toxicity
lethal triad
Palliative Care and Acute Oncology IntegrationRecoveryPackage
Dr Catherine O'Doherty, Consultant in Palliative Medicine, Trust Acute Oncology Lead and Lead Cancer Clinician, Basildon and Thurrock University Hospitals NHS Foundation Trust
Karen Andrews, Head of Nursing for Macmillan/Acute Oncology and EOL services, Basildon and Thurrock University Hospitals NHS Foundation Trust
A Case presentation of Massive Transfusion in post LSCS PPH patientDrShinyKajal
workup at blood centre
components issued
transfusion summary
criteria for massive transfusion
goal of massive transfusion
Indication protocol for massive transfusion for whole blood, prbc, ffp, cryo, platelets
Targets of resuscitation in massive blood loss
Complications of Massive Transfusion
citrate toxicity
lethal triad
Palliative Care and Acute Oncology IntegrationRecoveryPackage
Dr Catherine O'Doherty, Consultant in Palliative Medicine, Trust Acute Oncology Lead and Lead Cancer Clinician, Basildon and Thurrock University Hospitals NHS Foundation Trust
Karen Andrews, Head of Nursing for Macmillan/Acute Oncology and EOL services, Basildon and Thurrock University Hospitals NHS Foundation Trust
Portal hypertensive biliopathy management - case based learning -Dr Keyur BhattDrKeyurBhattMSMRCSEd
Portal hypertensive biliopathy is a very rare and deadly situation if not managed properly. A team of Gastrosurgeon, Gastro physicians, and Interventional radiologists should be involved before making any decision in this kind of cases.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Portal hypertensive biliopathy management - case based learning -Dr Keyur BhattDrKeyurBhattMSMRCSEd
Portal hypertensive biliopathy is a very rare and deadly situation if not managed properly. A team of Gastrosurgeon, Gastro physicians, and Interventional radiologists should be involved before making any decision in this kind of cases.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
3. A 71-year-old female r/o Gladstone, QLD
DOA - 06/03/23, seen by ED at 12:36 hrs
DOD - 22/03/23
Chief complaints:
• Was not able to cope at home because of Rt knee pain and had fracture of
head of right Humerus on 03/03/2023 when she had a fall at home, which
were being managed conservatively with collar and cuff with analgesia
• Also had bouts of diarrhoea? Antibiotic induced was Trimethoprim due to
presumed UTI (not evident on Urine MCS)
4. Past Medical History
• Post Fracture of head of right humerus after fall on 03/03/2023
(conservatively managed)
• Hypercholesterolemia on Atorvastatin
• T2DM Complicated by Right Charcot Foot on Metformin and Insulin
• Hypertension on Perindopril and Amlodipine
• COPD on Tiotropium and Oldaterol
• Hypomagnesemia On Magnesium
5. Examination
GENERAL EXAMINATION
• Palor +/Icterus-/ LAP- /Pedal Edema
++/Cyanosis-
• Vitals
• HR - 74
• BP- 125/86 mmHg supine
• Temp - 36.7 C
• RR - 20/min abdominothoracic
• SPO2- 92% on 2 Litres via NP
• JVP not mentioned
• Dehydrated???
SYSTEMIC EXAMINATION
• CNS- Conscious, oriented to
time/place/person. No neurological
deficit
• CVS-S1,S2 Heard ,No Murmur present
• P/A- Soft non tender , no
organomegaly
• R/S- Clear, no adventitious sounds.
• Stage 2 pressure area noted in sacral
and coccyx region with macerated
skin.
6. Investigations/Day 1
• Hb/WCC/PLT - 81/7.8/293000
• UREA/eGFR - 10.8/24
• Na/K - 124/4.8
• Bil(T/D) - 9/4
• AST/ALT/SAP - 26/28
• PROT/ALB - 53/22
• Covid RAT - Negative
• CXR showed the heart is mildly
enlarged, Pulmonary vasculature is at
the upper limits of normal. Bronchial
wall thickening is present, the lungs and
pleura are clear.
7. Provisional Diagnosis by ED
• Multifactorial Functional decline needing increased care needs in context of
diarrheal illness
• Decreased Mobility due to Rt Shoulder and Rt Knee pain
• Suboptimal COPD control
• Fluid Overload?
• Carers Fatigue
• Hearing Difficulty using hearing aid
8. Additional Diagnosis and Treatment By Medical Team:
(06/03/2023 at 15.55 hrs)
• Acute Kidney Injury Secondary to Multifactorial including Dehydration
(ongoing Diarrhoea) and Drugs including ARB and Metformin
• Anaemia
Treatment :
• Started on IV fluids 1 litre over 24 hours
• Haematinics sent at admission by medical team
• Metformin and Perindopril withheld in view of AKI
9. DAY 1 DAY 3 DAY 5
Hb/Tlc/PLT 76/8.0/203000 82/7.0/242000 83/7.6/279000
Urea/eGFR 10.8/24 9.9/27 10.9/28
Na/k 124/4.8 128/5.0 125/5.2
CRP Not available 136 88
Blood C/S - - -
Stool Sample MCS Negative
Urine MC/S done on
03/03/23
negative
10. Management/Day 1: (07/03/2023 at 10:50 hrs)
• Urine and Stool MCS were sent, which came back negative
• Chest X ray was planned if need for oxygen increased (currently 92% at
2 litres of oxygen via NP)
• Pt was referred for fracture clinic due to right humeral head fracture
• Bloods were repeated in morning, were followed at 13.24 hrs same day
Hb dropped to 70 from 76gm, CRP levels 170. It was decided to
transfuse 1 unit of blood and start patient on IV empiric antibiotics due
to raised CRP (unspecified infection focus), VTE prophylaxis was
modified in view of worsening eGFR, Pt was given more fluids.
11. Day 2: (08/03/23 at 9:30 hrs)
• Pt was found to have Iron deficiency: was transfused IV iron Polymaltose the
same day
• In view of decreased haemoglobin, Non Contrast CT Abdomen was planned
along with surgical referral for endoscopy and colonoscopy (CT happened on
09/03/2023 reporting was delayed till 12/03/2023)
• Also planned for CXR which showed signs of pulmonary oedema and patchy
consolidation at left base
• Pt remained stable, same evening (time not clear from notes), when pt
developed hypothermia with iron transfusion still ongoing, it was escalated to
on call PHO, same was discussed with Consultant, Iron Infusion stopped at
1830hrs
12. • On 09/03/2023, 11.00 hrs Pt felt better, CRP was noted 114, additional diagnosis of CAP
and HF was made (evident on recent CXR)
• Pt was started on IV furosemide 40 mg x 2 days (I/O and daily weight charting was
advised) IV Fluids were stopped, ECHO was arranged as an Outpatient
• Pt was reviewed by medical team on 10/03/2023 at 10:40 hrs, noted to have decreased
Sodium levels and raised blood pressure (180/92mmhg), Amlodipine was increased to
10 mg from 5 mg OD
• Same day at 1430 hrs, CT scan report (provisional report) was noted to have a mass in
caecum which may represent a frank neoplasm. Decision was made to further scan with
oral contrast and in view of the recent findings of CT scan, family meet was pondered
13. • Pt was reviewed on 11/03/2023 at 11:15 hrs was better QADDS=0, Nil O2 requirement.
Bloods noted to have Na 123, furosemide was stopped and fluid restriction in place now upto
1200ml. Decision to evaluate TFT was made came back normal.
• Pt. remained stable with intermittent oxygen of 0.5 litres via NP.
• CT abdomen with oral contrast showed mass lesion in ascending colon (final reportage).
• Surgeons were notified for a colonoscopy (in view of CT findings), HDU was notified of pre
anaesthetic assessment who advised for further diuresis and ECHO and asked to wait as pt
still requiring oxygen intermittently pt was stable till 15/03/2023.
14. Already 10 days in hospital contd.
• On 15/03/2023, CXR was noted to have bilateral pleural effusion,
consolidation with collapse was done in view of persistent need of oxygen
• Further furosemide dosage was increased to BD and Piptaz was introduced in
view of consolidation
• On 18/03/2023, Pt was seen at 16:20 hrs - PHO saw the patient stable,
sodium was noted to be 127 (improved), GFR 36 ? New baseline (earlier
baseline was 45), Hb 95 gm CRP dropped to 17. Now Pt was planned for
colonoscopy on 21/03/2023, if cleared by Anesthetist and remained stable
16. • Pt remained stable till next day, when nurses notified of hypothermia (34.6)
to the on-call PHO, <no notes? Workload weekend>, on 19/03/2023
• Med team saw the patient on 20/03/2023 at 0845 hrs, Pt remained stable,
decision to cease antibiotics and furosemide was reduced to OD (oral), Pt
awaiting colonoscopy, Anesthetist reviewed the pt (ECHO still not available,
could not be done -?long weekend)
• Nil notes by med team on 21/03/2023: day of colonoscopy ? May be due to Pt
being in OT - not clear with notes.
17. On 22/03/2023 at 01:39 hrs
• Pt developed hypothermia, was seen by ED team at night, Nil
complaints mentioned by the patient except feeling cold feet (already
having bear hugs), vitals remained stable - BP 130/65, HR 50 bpm,
temperature 33.2, RR 20 bpm, O2 94 % on 3 litres of oxygen via NP
(prior to this Pt was not on oxygen) chest developed bibasal crepts.
• Pt was continued on oxygen, put on IVF at 80 ml/hour and continued
with bear hugging
• Pt was re evaluated at 03:54 hrs by ED team as nurses alerted them that
the Pt was wet in the chest ? Volume overload, on chest auscultation
wide spread crackles were noted. Pt was given stat 40 mg of
furosemide, ceftriaxone 1 gm stat with metronidazole stat? reason? CXR
was advised too
18. Contd.22/03/2023
• MET call was pressed, timing not clear with the notes, due to low saturation
around 70 percentage on 3 litres of oxygen via N.P, Pt gasping already, ARP
consulted not for CPR and ICU based cares, GCS 3/15 Medical Consultant was
made aware
• Family was informed, all active treatment ceased, Pt was given IV hyoscine
and shifted to single room
• Pt passed away at 5:40 hrs. RIP
19. Final Diagnosis:
• Suspected Heart Failure (History of hypertension,T2DM, CKD, sepsis, vol.
overload)
• AKI On CKD ( secondary to Dehydration, ARB)
• Anaemia transfused bloods and IV Iron
• Post Fracture of head of right humerus after fall on 03/03/2023
(conservatively managed)
• Hypercholesterolemia on Atorvastatin
• T2DM Complicated by Right Charcot Foot on Metformin and Insulin
• Hypertension on Perindopril and Amlodipine
• COPD on Tiotropium and Oldaterol
• Hypomagnesemia On Magnesium